| 1 Change in HbA1c |
6 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.1 Follow up 3 months |
5 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 1.2 Follow up 6 months |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 1.3 Follow up 12 months |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 2 Improvement >0.5% in HbA1c |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
Totals not selected |
| 2.1 Follow up 3 months |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 2.2 Follow up 6 months |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 3 Severe hypoglycaemia |
4 |
|
Risk Ratio (IV, Fixed, 95% CI) |
Totals not selected |
| 3.1 Follow up 3 months |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 3.2 Follow up 6 months |
2 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 3.3 Follow up 12 months |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 4 Ketoacidosis |
4 |
|
Risk Ratio (IV, Fixed, 95% CI) |
Totals not selected |
| 4.1 Follow up 3 months |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 4.2 Follow up 6 months |
2 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 4.3 Follow up 12 months |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 5 Quality of life |
2 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 5.1 Physical health ‐ Follow up 6 months |
2 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 5.2 Mental health ‐ Follow up 6 months |
2 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 6 Patient satisfaction |
3 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 6.1 Follow up 3 months |
2 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 6.2 Follow up 6 months |
1 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 7 CGM‐derived hypoglycaemia |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 7.1 Follow up 12 months |
1 |
|
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
| 8 CGM‐derived hypoglycaemia |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 8.1 Follow up 6 months |
1 |
|
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
| 9 CGM‐derived hyperglycaemia |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 9.1 Follow up 12 months |
1 |
|
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
| 10 CGM‐derived hyperglycaemia |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 10.1 Follow up 6 months |
1 |
|
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |